The study examined the system’s efficacy as a trans-oral treatment for gastroesophageal reflux disease. The study found:
• 85 percent of GERD patients reduced proton pump inhibitor use by 50 percent or more
• Of these patients, 65 percent were able to eliminate medication use after six months
• 73 percent of patients reported improved quality of life scores of 50 percent or more
More Articles on Gastroenterology:
Adenoma Detection Rate: Lowering Colorectal Cancer Risk
12 Gastroenterologist Moves & Honors
Defining Leadership in the GI Field: 2 Gastroenterologists Discuss Their Strategies
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
